aluates Reports

$ 0.0

Automative

Global Adult and Pediatric Vaccines Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-17M10596

Global and United States Adult and Pediatric Vaccines Market Report Forecast 2022 2028

BUY CHAPTERS

Global Adult and Pediatric Vaccines Market Research Report 2025

Code: QYRE-Auto-17M10596

Report

September 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GlaxoSmithKline PLC

Sanofi

Merck

Novartis

Pfizer Inc

Astrazeneca plc

Johnson and Johnson

Takeda Pharmaceutical

Bavarian Nordic

LG Life Sciences

SINOVAC BIOTECH

Adult and Pediatric Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Adult and Pediatric Vaccines Market

The global market for Adult and Pediatric Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A vaccine is a biological preparation that provides active acquired immunity to a particular disease.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Adult and Pediatric Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult and Pediatric Vaccines.

The Adult and Pediatric Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adult and Pediatric Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Adult and Pediatric Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Adult and Pediatric Vaccines Market Report

Report Metric	Details
Report Name	Adult and Pediatric Vaccines Market
CAGR	5%
Segment by Type	Adult Vaccines Pediatric Vaccines
Segment by Application	Hospitals Medical Care Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Johnson and Johnson, Takeda Pharmaceutical, Bavarian Nordic, LG Life Sciences, Sinovac Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adult and Pediatric Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Adult and Pediatric Vaccines Market report?

Ans: The main players in the Adult and Pediatric Vaccines Market are GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Johnson and Johnson, Takeda Pharmaceutical, Bavarian Nordic, LG Life Sciences, Sinovac Biotech

What are the Application segmentation covered in the Adult and Pediatric Vaccines Market report?

Ans: The Applications covered in the Adult and Pediatric Vaccines Market report are Hospitals, Medical Care Centers, Others

What are the Type segmentation covered in the Adult and Pediatric Vaccines Market report?

Ans: The Types covered in the Adult and Pediatric Vaccines Market report are Adult Vaccines, Pediatric Vaccines

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Adult and Pediatric Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Adult Vaccines

1.2.3 Pediatric Vaccines

1.3 Market by Application

1.3.1 Global Adult and Pediatric Vaccines Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Medical Care Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Adult and Pediatric Vaccines Market Perspective (2020-2031)

2.2 Global Adult and Pediatric Vaccines Growth Trends by Region

2.2.1 Global Adult and Pediatric Vaccines Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Adult and Pediatric Vaccines Historic Market Size by Region (2020-2025)

2.2.3 Adult and Pediatric Vaccines Forecasted Market Size by Region (2026-2031)

2.3 Adult and Pediatric Vaccines Market Dynamics

2.3.1 Adult and Pediatric Vaccines Industry Trends

2.3.2 Adult and Pediatric Vaccines Market Drivers

2.3.3 Adult and Pediatric Vaccines Market Challenges

2.3.4 Adult and Pediatric Vaccines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Adult and Pediatric Vaccines Players by Revenue

3.1.1 Global Top Adult and Pediatric Vaccines Players by Revenue (2020-2025)

3.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2020-2025)

3.2 Global Adult and Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Adult and Pediatric Vaccines Revenue

3.4 Global Adult and Pediatric Vaccines Market Concentration Ratio

3.4.1 Global Adult and Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Adult and Pediatric Vaccines Revenue in 2024

3.5 Global Key Players of Adult and Pediatric Vaccines Head office and Area Served

3.6 Global Key Players of Adult and Pediatric Vaccines, Product and Application

3.7 Global Key Players of Adult and Pediatric Vaccines, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Adult and Pediatric Vaccines Breakdown Data by Type

4.1 Global Adult and Pediatric Vaccines Historic Market Size by Type (2020-2025)

4.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2026-2031)

5 Adult and Pediatric Vaccines Breakdown Data by Application

5.1 Global Adult and Pediatric Vaccines Historic Market Size by Application (2020-2025)

5.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Adult and Pediatric Vaccines Market Size (2020-2031)

6.2 North America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Adult and Pediatric Vaccines Market Size by Country (2020-2025)

6.4 North America Adult and Pediatric Vaccines Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Adult and Pediatric Vaccines Market Size (2020-2031)

7.2 Europe Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Adult and Pediatric Vaccines Market Size by Country (2020-2025)

7.4 Europe Adult and Pediatric Vaccines Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Adult and Pediatric Vaccines Market Size (2020-2031)

8.2 Asia-Pacific Adult and Pediatric Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2020-2025)

8.4 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Adult and Pediatric Vaccines Market Size (2020-2031)

9.2 Latin America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Adult and Pediatric Vaccines Market Size by Country (2020-2025)

9.4 Latin America Adult and Pediatric Vaccines Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Adult and Pediatric Vaccines Market Size (2020-2031)

10.2 Middle East & Africa Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2020-2025)

10.4 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Details

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Introduction

11.1.4 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.1.5 GlaxoSmithKline Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Adult and Pediatric Vaccines Introduction

11.2.4 Sanofi Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Adult and Pediatric Vaccines Introduction

11.3.4 Merck Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.3.5 Merck Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Adult and Pediatric Vaccines Introduction

11.4.4 Novartis Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Adult and Pediatric Vaccines Introduction

11.5.4 Pfizer Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Adult and Pediatric Vaccines Introduction

11.6.4 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Johnson and Johnson

11.7.1 Johnson and Johnson Company Details

11.7.2 Johnson and Johnson Business Overview

11.7.3 Johnson and Johnson Adult and Pediatric Vaccines Introduction

11.7.4 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.7.5 Johnson and Johnson Recent Development

11.8 Takeda Pharmaceutical

11.8.1 Takeda Pharmaceutical Company Details

11.8.2 Takeda Pharmaceutical Business Overview

11.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Introduction

11.8.4 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.8.5 Takeda Pharmaceutical Recent Development

11.9 Bavarian Nordic

11.9.1 Bavarian Nordic Company Details

11.9.2 Bavarian Nordic Business Overview

11.9.3 Bavarian Nordic Adult and Pediatric Vaccines Introduction

11.9.4 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.9.5 Bavarian Nordic Recent Development

11.10 LG Life Sciences

11.10.1 LG Life Sciences Company Details

11.10.2 LG Life Sciences Business Overview

11.10.3 LG Life Sciences Adult and Pediatric Vaccines Introduction

11.10.4 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.10.5 LG Life Sciences Recent Development

11.11 Sinovac Biotech

11.11.1 Sinovac Biotech Company Details

11.11.2 Sinovac Biotech Business Overview

11.11.3 Sinovac Biotech Adult and Pediatric Vaccines Introduction

11.11.4 Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2020-2025)

11.11.5 Sinovac Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Sanofi

Merck

Novartis

Pfizer Inc

Astrazeneca plc

Johnson and Johnson

Takeda Pharmaceutical

Bavarian Nordic

LG Life Sciences

SINOVAC BIOTECH

List of Tables

Table 1. Global Adult and Pediatric Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Adult Vaccines

Table 3. Key Players of Pediatric Vaccines

Table 4. Global Adult and Pediatric Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Adult and Pediatric Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Adult and Pediatric Vaccines Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Adult and Pediatric Vaccines Market Share by Region (2020-2025)

Table 8. Global Adult and Pediatric Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Adult and Pediatric Vaccines Market Share by Region (2026-2031)

Table 10. Adult and Pediatric Vaccines Market Trends

Table 11. Adult and Pediatric Vaccines Market Drivers

Table 12. Adult and Pediatric Vaccines Market Challenges

Table 13. Adult and Pediatric Vaccines Market Restraints

Table 14. Global Adult and Pediatric Vaccines Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Adult and Pediatric Vaccines Market Share by Players (2020-2025)

Table 16. Global Top Adult and Pediatric Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult and Pediatric Vaccines as of 2024)

Table 17. Ranking of Global Top Adult and Pediatric Vaccines Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Adult and Pediatric Vaccines Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Adult and Pediatric Vaccines, Headquarters and Area Served

Table 20. Global Key Players of Adult and Pediatric Vaccines, Product and Application

Table 21. Global Key Players of Adult and Pediatric Vaccines, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Adult and Pediatric Vaccines Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2020-2025)

Table 25. Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2026-2031)

Table 27. Global Adult and Pediatric Vaccines Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2020-2025)

Table 29. Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2026-2031)

Table 31. North America Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Adult and Pediatric Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 46. GlaxoSmithKline Company Details

Table 47. GlaxoSmithKline Business Overview

Table 48. GlaxoSmithKline Adult and Pediatric Vaccines Product

Table 49. GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 50. GlaxoSmithKline Recent Development

Table 51. Sanofi Company Details

Table 52. Sanofi Business Overview

Table 53. Sanofi Adult and Pediatric Vaccines Product

Table 54. Sanofi Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 55. Sanofi Recent Development

Table 56. Merck Company Details

Table 57. Merck Business Overview

Table 58. Merck Adult and Pediatric Vaccines Product

Table 59. Merck Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 60. Merck Recent Development

Table 61. Novartis Company Details

Table 62. Novartis Business Overview

Table 63. Novartis Adult and Pediatric Vaccines Product

Table 64. Novartis Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 65. Novartis Recent Development

Table 66. Pfizer Company Details

Table 67. Pfizer Business Overview

Table 68. Pfizer Adult and Pediatric Vaccines Product

Table 69. Pfizer Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 70. Pfizer Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Adult and Pediatric Vaccines Product

Table 74. AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 75. AstraZeneca Recent Development

Table 76. Johnson and Johnson Company Details

Table 77. Johnson and Johnson Business Overview

Table 78. Johnson and Johnson Adult and Pediatric Vaccines Product

Table 79. Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 80. Johnson and Johnson Recent Development

Table 81. Takeda Pharmaceutical Company Details

Table 82. Takeda Pharmaceutical Business Overview

Table 83. Takeda Pharmaceutical Adult and Pediatric Vaccines Product

Table 84. Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 85. Takeda Pharmaceutical Recent Development

Table 86. Bavarian Nordic Company Details

Table 87. Bavarian Nordic Business Overview

Table 88. Bavarian Nordic Adult and Pediatric Vaccines Product

Table 89. Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 90. Bavarian Nordic Recent Development

Table 91. LG Life Sciences Company Details

Table 92. LG Life Sciences Business Overview

Table 93. LG Life Sciences Adult and Pediatric Vaccines Product

Table 94. LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 95. LG Life Sciences Recent Development

Table 96. Sinovac Biotech Company Details

Table 97. Sinovac Biotech Business Overview

Table 98. Sinovac Biotech Adult and Pediatric Vaccines Product

Table 99. Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)

Table 100. Sinovac Biotech Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Adult and Pediatric Vaccines Picture

Figure 2. Global Adult and Pediatric Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Adult and Pediatric Vaccines Market Share by Type: 2024 VS 2031

Figure 4. Adult Vaccines Features

Figure 5. Pediatric Vaccines Features

Figure 6. Global Adult and Pediatric Vaccines Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Adult and Pediatric Vaccines Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Medical Care Centers Case Studies

Figure 10. Others Case Studies

Figure 11. Adult and Pediatric Vaccines Report Years Considered

Figure 12. Global Adult and Pediatric Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Adult and Pediatric Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Adult and Pediatric Vaccines Market Share by Region: 2024 VS 2031

Figure 15. Global Adult and Pediatric Vaccines Market Share by Players in 2024

Figure 16. Global Top Adult and Pediatric Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult and Pediatric Vaccines as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Adult and Pediatric Vaccines Revenue in 2024

Figure 18. North America Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Adult and Pediatric Vaccines Market Share by Country (2020-2031)

Figure 20. United States Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Adult and Pediatric Vaccines Market Share by Country (2020-2031)

Figure 24. Germany Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Adult and Pediatric Vaccines Market Share by Region (2020-2031)

Figure 32. China Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Adult and Pediatric Vaccines Market Share by Country (2020-2031)

Figure 40. Mexico Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Adult and Pediatric Vaccines Market Share by Country (2020-2031)

Figure 44. Turkey Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. GlaxoSmithKline Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 48. Sanofi Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 49. Merck Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 53. Johnson and Johnson Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 55. Bavarian Nordic Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 56. LG Life Sciences Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 57. Sinovac Biotech Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Vaccines for the Elderly Market Research Report 2024

Global Seasonal Vaccines Market Research Report 2024

Global Infant and Child Multiple Vaccine Market Research Report 2024

Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Consumption Type Vaccine Market Research Report 2024

Global HIV Vaccine Market Research Report 2025

Global Multiple Vaccine Market Research Report 2024

Human Vaccine Adjuvants Market

Global Live Vaccines Market Research Report 2024

Global Vaccines For Children Market Insights Forecast to 2030

Global HIV and AIDS Vaccine Market Research Report 2024

Paediatric Vaccine Market

Global Vaccination Device Market Research Report 2024

Global Norovirus Vaccine Market Research Report 2024

Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024

Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combination Vaccine and Multivalent Vaccine Market Research Report 2024

Global Biopharmaceutical and Vaccines Market Research Report 2024

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions